A new study reports people with ALs may have a genetic mutation that causes SOD1 to aggregate motor neurons in the brain and spinal cord.
Researchers pin down the structure of toxic clumps of a protein associated with a large number of ALS cases. The findings could help open the door to developing new drugs to treat the disease.
Researchers have identified a transport defect in models of familial ALS which leads to the accumulation of damaged components.
Researchers use techniques which illuminates subtle changes in proteins and uncover new insights into the underlying causes of ALS.
A new study suggest specific protein instability as a cause of ALS.
Researchers discover Alzheimer's disease, and other neurodegenerative conditions could be linked to prion-like proteins.
Researchers discover a recently approved epilepsy medication could also help to treat ALS.
Researchers pinpoint an error in protein formation which could be the root of ALS.
Researchers discover ALS is transmitted from cell to cell, suggesting the spread of the disease could be blocked.
New research could help find a solution to slowing down the progression of motor neuron disease.
By reducing the expression of the SOD1 gene, ALS onset and progression is slowed, a new study suggests.
A new study finds slowdowns in the transport and delivery of proteins, nutrients and signaling molecules within nerve cells could contribute to the development of ALS.
